Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Expert Opinion on Pharmacotherapy
|
October 4, 2016
Starting aripiprazole long-acting-once-a-month early in treatment: why, how and for whom? Expert consensus and practical recommendations by a panel of Italian clinicians
Giovanni Amodeo, Chiara Candiracci, Ilaria Capecci, et al.
Frontiers in Psychiatry
|
November 22, 2021
Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression: A Real-World, Prospective Study
Giulio Perugi, Paola Calò, Sergio De Filippis, et al.
Current Neuropharmacology
|
January 17, 2025
Partial Dopamine D2/3 Agonists and Dual Disorders: A Retrospective-Cohort Study in a Real-World Clinical Setting on Patients with Schizophrenia Spectrum Disorders and Cannabis Use Disorder
Giada Trovini, Ginevra Lombardozzi, Georgios D Kotzalidis, et al.
Frontiers in Psychiatry
|
January 24, 2020
Aripiprazole Long-Acting Injection During First Episode Schizophrenia-An Exploratory Analysis
Gloria Giordano, Lorenzo Tomassini, Ilaria Cuomo, et al.
Current Neuropharmacology
|
March 11, 2022
Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma
Sergio De Filippis, Ginevra Lombardozzi, Marta Matrone, et al.
Therapeutic Advances in Psychopharmacology
|
March 4, 2017
Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study
Sergio De Filippis, Ilaria Cuomo, Georgios D Kotzalidis, et al.
Annals of General Psychiatry
|
August 10, 2022
Mental health in Italy after two years of COVID-19 from the perspective of 1281 Italian physicians: looking back to plan forward
Alessandro Cuomo, Mario Amore, Maria Felice Arezzo, et al.
Journal of Psychiatric Practice
|
March 19, 2014
Neurological soft signs discriminate schizophrenia from bipolar disorder
Silvia Rigucci, Giorgia Dimitri-Valente, Gabriele Mandarelli, et al.
Neuropsychiatric Disease and Treatment
|
April 17, 2010
Psychiatric comorbidity and suicide risk in patients with chronic migraine
Maurizio Pompili, Gianluca Serafini, Daniela Di Cosimo, et al.
The Journal of Headache and Pain
|
December 20, 2005
Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A>G) and migraine
Patrizia Lulli, Simonetta Trabace, Marina Morellini, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Expert Opinion on Pharmacotherapy
|
October 4, 2016
Starting aripiprazole long-acting-once-a-month early in treatment: why, how and for whom? Expert consensus and practical recommendations by a panel of Italian clinicians
Giovanni Amodeo, Chiara Candiracci, Ilaria Capecci, et al.
Frontiers in Psychiatry
|
November 22, 2021
Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression: A Real-World, Prospective Study
Giulio Perugi, Paola Calò, Sergio De Filippis, et al.
Current Neuropharmacology
|
January 17, 2025
Partial Dopamine D2/3 Agonists and Dual Disorders: A Retrospective-Cohort Study in a Real-World Clinical Setting on Patients with Schizophrenia Spectrum Disorders and Cannabis Use Disorder
Giada Trovini, Ginevra Lombardozzi, Georgios D Kotzalidis, et al.
Frontiers in Psychiatry
|
January 24, 2020
Aripiprazole Long-Acting Injection During First Episode Schizophrenia-An Exploratory Analysis
Gloria Giordano, Lorenzo Tomassini, Ilaria Cuomo, et al.
Current Neuropharmacology
|
March 11, 2022
Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma
Sergio De Filippis, Ginevra Lombardozzi, Marta Matrone, et al.
Therapeutic Advances in Psychopharmacology
|
March 4, 2017
Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study
Sergio De Filippis, Ilaria Cuomo, Georgios D Kotzalidis, et al.
Annals of General Psychiatry
|
August 10, 2022
Mental health in Italy after two years of COVID-19 from the perspective of 1281 Italian physicians: looking back to plan forward
Alessandro Cuomo, Mario Amore, Maria Felice Arezzo, et al.
Journal of Psychiatric Practice
|
March 19, 2014
Neurological soft signs discriminate schizophrenia from bipolar disorder
Silvia Rigucci, Giorgia Dimitri-Valente, Gabriele Mandarelli, et al.
Neuropsychiatric Disease and Treatment
|
April 17, 2010
Psychiatric comorbidity and suicide risk in patients with chronic migraine
Maurizio Pompili, Gianluca Serafini, Daniela Di Cosimo, et al.
The Journal of Headache and Pain
|
December 20, 2005
Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A>G) and migraine
Patrizia Lulli, Simonetta Trabace, Marina Morellini, et al.
Page
of 7